GSKVX000000044501

**GSKVX000000044501** is an investigational GSK prophylactic vaccine active substance being evaluated as part of a urinary tract infection vaccine program. It is being studied for prevention of new *Escherichia coli*-associated urinary tract infections, with safety, reactogenicity, immunogenicity, and clinical efficacy assessed in adults and in females aged 18 to 64 years. Public trial information identifies it as a vaccine-related active substance administered in an intramuscular suspension-for-injection product; its precise antigen composition, vaccine platform, and adjuvant system have not been publicly disclosed.

Other names

9-valent extraintestinal pathogenic Escherichia coli bioconjugate vaccineExPEC-9VExPEC9VExPEC 9V